Si-Bone (SIBN) Depreciation & Amortization (CF) (2017 - 2026)
Si-Bone's (SIBN) quarterly Depreciation & Amortization (CF) came in at $1.6 million in Q1 2026, up 26.53% year-on-year from $1.3 million in Q1 2025, and down 1.28% quarter-over-quarter from $1.6 million in Q4 2025.
Si-Bone (SIBN) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
Si-Bone's Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 26.53% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $6.1 million, a 33.73% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, up 31.77% from the prior year.
- Depreciation & Amortization (CF) fell to $1.6 million in Q1 2026 per SIBN's latest filing, from $1.6 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.6 million in Q4 2025 and bottomed at $713000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $1.2 million (2024), against an average of $1.2 million.
- Across the five-year window, Depreciation & Amortization (CF) surged 109.71% in 2022 and decreased 29.22% in 2024, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $1.0 million in 2022, then soared by 56.99% to $1.6 million in 2023, then slipped by 22.89% to $1.2 million in 2024, then soared by 35.04% to $1.6 million in 2025, then retreated by 1.28% to $1.6 million in 2026.
- Per Business Quant, the three latest SIBN Depreciation & Amortization (CF) figures stand at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Si-Bone | 724.02 Mn | 579.33 Mn | 41.94 Mn | 1.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.62 Mn |
| Mar 31, 2026 | 1.62 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 992,000.00 |
| Jun 30, 2024 | 992,000.00 |
| Mar 31, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.57 Mn |
| Dec 31, 2023 | 1.57 Mn |